Recursion Pharmaceuticals Inc.
Clinical trials sponsored by Recursion Pharmaceuticals Inc., explained in plain language.
-
New drug aims to tame polyp growth in rare genetic condition
Disease control Recruiting nowThis study tests an experimental drug called REC-4881 in 67 adults with familial adenomatous polyposis (FAP), a genetic condition that causes many polyps in the gut and raises cancer risk. The goal is to see if the drug can safely reduce the number and size of polyps. Participant…
Phase: PHASE1, PHASE2 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control
Last updated May 26, 2026 10:40 UTC
-
New daily pill trial aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis study tests an experimental daily pill, REC-1245, in people with advanced solid tumors or lymphomas that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors or control the disease. About 170 participants will take …
Phase: PHASE1, PHASE2 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control
Last updated May 20, 2026 11:57 UTC